BELANO medical

BELANO medical was a German microbiome-focused biotechnology and consumer health company that developed and commercialized products based on beneficial microorganisms and microbiotic active ingredients. Its portfolio spanned medical skin care, throat and mouth care, stomach care, wound-related products, and hygiene applications, with marketed ingredients and products including stimulans, ibiotics med, and salvans. The company positioned itself at the intersection of biotech R&D and consumer/medical product commercialization, and also pursued B2B distribution and private-label partnerships. BELANO medical collaborated with partners such as Henkel Beauty Care, Müller, tradichem, b.value AG, and Deutsche Biotech Innovativ AG. The company entered insolvency proceedings in November 2023, was placed into liquidation in February 2024, and was subsequently acquired/merged in April 2024.